Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026)
Perrigo's (PRGO) quarterly Long-Term Deferred Tax came in at $4.7 million in Q1 2026, down 12.96% year-on-year from $5.4 million in Q1 2025, and up 42.42% on a QoQ basis from $3.3 million in Q4 2025.
Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Long-Term Deferred Tax data on file, last reported at $4.7 million in Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 12.96% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $4.7 million, a 12.96% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 35.29% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $4.7 million, up from $3.3 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for PRGO reached as high as $64.2 million in Q3 2025 and fell as low as $3.3 million in Q4 2025.
- Historically, Long-Term Deferred Tax has averaged $15.8 million across 5 years, with a median of $6.9 million in 2022.
- Across the five-year window, Long-Term Deferred Tax sank 88.31% in 2022 and jumped 359.02% in 2024, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $7.1 million in 2022, then jumped by 263.38% to $25.8 million in 2023, then tumbled by 80.23% to $5.1 million in 2024, then tumbled by 35.29% to $3.3 million in 2025, then jumped by 42.42% to $4.7 million in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $4.7 million in Q1 2026, $3.3 million in Q4 2025, and $64.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 4.70 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 27, 2025 | 64.20 Mn |
| Jun 28, 2025 | 48.10 Mn |
| Mar 29, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.10 Mn |
| Sep 28, 2024 | 22.40 Mn |
| Jun 29, 2024 | 13.80 Mn |
| Mar 30, 2024 | 28.00 Mn |
| Dec 31, 2023 | 25.80 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jul 1, 2023 | 6.30 Mn |
| Apr 1, 2023 | 6.10 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Oct 1, 2022 | 7.70 Mn |
| Jul 2, 2022 | 6.90 Mn |
| Apr 2, 2022 | 6.70 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Oct 2, 2021 | 40.20 Mn |
| Jul 3, 2021 | 49.00 Mn |